Literature DB >> 27780991

Neuromodulation for Addiction by Transcranial Direct Current Stimulation: Opportunities and Challenges.

Shahid Bashir1, Woo-Kyoung Yoo2.   

Abstract

The field of neuromodulation encompasses a wide spectrum of interventional technologies that modify the pathological activity within the nervous system to achieve a therapeutic effect. Therapy, including transcranial direct current stimulation, has shown promising results across a range of neurological and neuropsychiatric disorders. This article reviews the state-of-the-art of neuromodulation for addiction and discusses the opportunities and challenges available for clinicians and researchers interested in advancing the neuromodulation therapy. A neuromodulation-based approach for addiction has the advantage that the effects might be immediate and selective to the dysfunction. If an alteration in the mechanisms of brain plasticity indeed represents the proximal cause for nicotine-associated cognitive decline and is a critical contributor to the early pathogenesis of addiction, novel interventions that forestall the development of symptoms might be possible.

Entities:  

Keywords:  Neuroengineering; Neuromodulation; Transcranial direct current stimulation

Year:  2016        PMID: 27780991      PMCID: PMC5075739          DOI: 10.1159/000449485

Source DB:  PubMed          Journal:  Ann Neurosci        ISSN: 0972-7531


  25 in total

1.  Deep brain stimulation for treatment-resistant depression.

Authors:  Helen S Mayberg; Andres M Lozano; Valerie Voon; Heather E McNeely; David Seminowicz; Clement Hamani; Jason M Schwalb; Sidney H Kennedy
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

2.  Cortical stimulation of the prefrontal cortex with transcranial direct current stimulation reduces cue-provoked smoking craving: a randomized, sham-controlled study.

Authors:  Felipe Fregni; Paola Liguori; Shirley Fecteau; Michael A Nitsche; Alvaro Pascual-Leone; Paulo S Boggio
Journal:  J Clin Psychiatry       Date:  2008-01       Impact factor: 4.384

3.  Frequency-dependent electrical stimulation of the visual cortex.

Authors:  Ryota Kanai; Leila Chaieb; Andrea Antal; Vincent Walsh; Walter Paulus
Journal:  Curr Biol       Date:  2008-11-20       Impact factor: 10.834

4.  Cumulative priming effects of cortical stimulation on smoking cue-induced craving.

Authors:  Paulo Sergio Boggio; Paola Liguori; Natasha Sultani; Larissa Rezende; Shirley Fecteau; Felipe Fregni
Journal:  Neurosci Lett       Date:  2009-07-18       Impact factor: 3.046

5.  Neural systems and cue-induced cocaine craving.

Authors:  Katherine R Bonson; Steven J Grant; Carlo S Contoreggi; Jonathan M Links; Janet Metcalfe; H Lloyd Weyl; Varughese Kurian; Monique Ernst; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2002-03       Impact factor: 7.853

Review 6.  A technical guide to tDCS, and related non-invasive brain stimulation tools.

Authors:  A J Woods; A Antal; M Bikson; P S Boggio; A R Brunoni; P Celnik; L G Cohen; F Fregni; C S Herrmann; E S Kappenman; H Knotkova; D Liebetanz; C Miniussi; P C Miranda; W Paulus; A Priori; D Reato; C Stagg; N Wenderoth; M A Nitsche
Journal:  Clin Neurophysiol       Date:  2015-11-22       Impact factor: 3.708

7.  Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males.

Authors:  Fleur Zijlstra; Jan Booij; Wim van den Brink; Ingmar H A Franken
Journal:  Eur Neuropsychopharmacol       Date:  2008-04       Impact factor: 4.600

8.  Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression.

Authors:  Donald A Malone; Darin D Dougherty; Ali R Rezai; Linda L Carpenter; Gerhard M Friehs; Emad N Eskandar; Scott L Rauch; Steven A Rasmussen; Andre G Machado; Cynthia S Kubu; Audrey R Tyrka; Lawrence H Price; Paul H Stypulkowski; Jonathon E Giftakis; Mark T Rise; Paul F Malloy; Stephen P Salloway; Benjamin D Greenberg
Journal:  Biol Psychiatry       Date:  2008-10-08       Impact factor: 13.382

9.  An investigation into the effects of tDCS dose on cognitive performance over time in patients with schizophrenia.

Authors:  Kate E Hoy; Sara L Arnold; Melanie R L Emonson; Zafiris J Daskalakis; Paul B Fitzgerald
Journal:  Schizophr Res       Date:  2014-04-02       Impact factor: 4.939

10.  Optogenetics.

Authors:  Karl Deisseroth
Journal:  Nat Methods       Date:  2010-12-20       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.